Oryzon Genomics SA (ES:ORY) has released an update. Oryzon Genomics has reported a reduction in R&D investments and a slight increase in revenue from its own assets for Q3 2024, despite a net loss of ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at ...

SAN FRANCISCO--(BUSINESS WIRE)--Stanford University and Cofactor Genomics, the company bridging the precision medicine gap, announced today that Stanford will join Cofactor’s PREDAPT (Predicting ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research ...

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent diseases. With the launch, Genomics claims its test is the first product in ...

The past decade has delivered landmark advances in human and medical genomics that shape how we understand disease mechanisms ...

I am the Co-founder and CEO of HaystackAnalytics, a life sciences deep-tech company working in clinical genomics. At Haystack ...

Patient education and navigation significantly improve genomic testing uptake and clinical trial participation, addressing disparities in trial enrollment among underrepresented groups. Video-based ...